---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008988"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:29:52.315534+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IRADIMED uplists to Nasdaq Global Market, trading starts June 14, 2024 under IRMD

## Summary
- Nasdaq approved transfer from Capital Market to Global Market, effective June 14, 2024.
- Ticker remains 'IRMD'; no stockholder action required.
- CEO Roger Susi highlights continued growth and enhanced visibility from higher listing standards.
- Nasdaq Global Market includes ~1,450 companies with stricter financial and governance requirements.

## SEC filing metadata
- accession: 0001558370-24-008988
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837024008988/0001558370-24-008988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837024008988/irmd-20240605x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008988
- JSON: https://secwatch.observer/filing/0001558370-24-008988.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
